NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | 99.9% | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -642.1% | – |
| Net Income | -$0 | -$0 | -$0 | – |
| % Margin | – | – | -643.8% | – |
| EPS Diluted | -53.93 | -7.33 | -2.86 | – |
| % Growth | -635.7% | -156.3% | – | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | – |
| Capital Expenditures | $0 | -$0 | $0 | – |
| Free Cash Flow | -$0 | -$0 | -$0 | – |